IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 40 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $706,000 | +109.5% | 535,578 | +191.2% | 0.00% | – |
Q1 2018 | $337,000 | -48.4% | 183,900 | -40.7% | 0.00% | – |
Q4 2017 | $653,000 | +203.7% | 310,011 | +220.7% | 0.00% | – |
Q3 2017 | $215,000 | +4.9% | 96,675 | -19.5% | 0.00% | – |
Q2 2017 | $205,000 | +230.6% | 120,079 | +368.5% | 0.00% | – |
Q1 2017 | $62,000 | -36.1% | 25,628 | -60.7% | 0.00% | – |
Q4 2016 | $97,000 | -79.2% | 65,156 | -64.3% | 0.00% | – |
Q3 2016 | $466,000 | +80.6% | 182,395 | +7.3% | 0.00% | – |
Q2 2016 | $258,000 | -17.6% | 170,010 | +7.2% | 0.00% | – |
Q1 2016 | $313,000 | -95.3% | 158,548 | -92.6% | 0.00% | -100.0% |
Q4 2015 | $6,641,000 | -2.1% | 2,149,861 | +6.2% | 0.01% | 0.0% |
Q3 2015 | $6,780,000 | -12.7% | 2,024,779 | -3.3% | 0.01% | 0.0% |
Q2 2015 | $7,768,000 | +10.3% | 2,094,797 | +10.3% | 0.01% | +25.0% |
Q1 2015 | $7,041,000 | +12.3% | 1,898,682 | +33.5% | 0.00% | 0.0% |
Q4 2014 | $6,268,000 | +82.8% | 1,421,786 | -5.1% | 0.00% | +100.0% |
Q3 2014 | $3,429,000 | +458.5% | 1,498,429 | +604.5% | 0.00% | – |
Q2 2014 | $614,000 | +320.5% | 212,690 | +277.7% | 0.00% | – |
Q1 2014 | $146,000 | -82.0% | 56,310 | -67.8% | 0.00% | -100.0% |
Q4 2013 | $810,000 | +800.0% | 175,000 | +236.0% | 0.00% | – |
Q3 2013 | $90,000 | – | 52,091 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 2,030,604 | $4,285,000 | 0.70% |
Virtus ETF Advisers LLC | 180,348 | $381,000 | 0.48% |
Bain Capital Public Equity Management, LLC | 4,564,744 | $9,632,000 | 0.35% |
Baker Brothers Advisors | 18,315,802 | $38,646,000 | 0.34% |
Stanley-Laman Group, Ltd. | 483,773 | $1,021,000 | 0.22% |
FIRST MIDWEST BANK TRUST DIVISION | 493,689 | $1,042,000 | 0.13% |
GMT CAPITAL CORP | 3,875,546 | $8,178,000 | 0.08% |
Vident Investment Advisory, LLC | 640,270 | $1,351,000 | 0.06% |
SABBY MANAGEMENT, LLC | 307,987 | $650,000 | 0.06% |
Palo Alto Investors LP | 616,355 | $1,301,000 | 0.06% |